Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UPDATE 1-Canadian pharmaceutical billionaire, wife found dead in Toronto

Published 2017-12-15, 07:20 p/m
Updated 2017-12-15, 07:30 p/m
UPDATE 1-Canadian pharmaceutical billionaire, wife found dead in Toronto

(Adds details from police, company)

By Julie Gordon

Dec 15 (Reuters) - The billionaire founder of Canadian pharmaceutical firm Apotex Inc, Barry Sherman, and his wife Honey, were found dead in their Toronto home on Friday under circumstances that police described as "suspicious."

Police told reporters they were investigating the deaths after finding the couple in their northeast Toronto home when responding to a medical call just before noon (1700 GMT).

"The circumstances of their death appear suspicious and we are treating it that way," said Constable David Hopkinson.

Sherman founded Apotex in 1974, a company the firm says is now the world's No. 7 generic drugmaker. He stepped down as chief executive in 2012, but stayed on as executive chairman.

"All of us at Apotex are deeply shocked and saddened by this news and our thoughts and prayers are with the family at this time," the company said in a statement.

Privately held Apotex says it is the largest Canadian-owned pharmaceutical firm, with annual sales of more than C$2 billion.

Ontario's health minister, Eric Hoskins, described the couple in a tweet as "wonderful human beings, incredible philanthropists, great leaders in healthcare."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.